Grants and Contracts Details
Description
II. Scientific summary
The loss of sight that results from diseases like retinitis pigmentosa (RP) and macular
degeneration is especially devastating because it is currently irreversible. Therapeutic
strategies such as gene therapy and cell-based transplantation hold great potential, but
are only an option for a small group of patients, and several technical and theoretical
challenges must be overcome before they become widely available. One
complementary approach to treating retinal degenerative diseases is to find ways to
promote endogenous regeneration in the diseased or damaged retina. Across the
animal kingdom, several vertebrate species, including fish, amphibians, and reptiles, are
capable of regenerating their retinal neurons in response to acute injury. Research into
the mechanisms regulating retinal regeneration in these species has yielded valuable
information and highlighted the critical role of retinal Müller glia as the source of
regenerating cells. However, to translate these findings into therapies, it would be
helpful to incorporate an animal model that more closely mirrors human ocular
physiology to probe the regenerative potential of the mammalian retina. In recent years,
spiny mice (Acomys) have become the focus of intense research for their ability to heal
skin wounds without scars. Further studies have revealed that spiny mice exhibit
regenerative capacity beyond the skin, in tissues such as the heart and the spinal cord.
This raises the question of whether these mammals can regenerate retinal neurons in
response to damage. During the previous funding period, we demonstrated that the
spiny mouse retina mounts a pro-regenerative response to acute retinal damage, and
that this response encompasses both Müller glia proliferation and the induction of
neurogenic gene expression, neither of which are observed in the non-regenerating
Mus musculus retina following damage. This positions Acomys as an ideal animal
model with which to address longstanding questions about regenerative potential in the
mammalian retina. One critical knowledge gap involves the role of innate immune cells
and inflammation in the regenerative process. In fully regenerating species such as the
zebrafish, acute retinal damage induces infiltration of activated microglia as well as
inflammatory signaling via the Jack/Stat and TNF-alpha pathways; these immune
responses are required to promote efficient retinal regeneration. In contrast, Jak/Stat
signaling inhibits the neurogenic potential of Müller glia in the chick retina, and microglia
suppress retinal regenerative responses elicited by forced expression of Ascl1 in Mus
Musculus. By studying Acomys, a mammal with natural retinal regenerative capacity,
we now have a unique opportunity to address these contradictory findings. To do this,
we propose two specific aims: 1) we will ascertain whether microglial activation is
required for the pro-regenerative program in Acomys retina following acute damage;
and 2) we will determine how inflammatory signaling through the Jack/Stat and TNF-
alpha pathways influences the Acomys pro-regenerative response. The results of our
studies will address critical gaps in our understanding of how cross-talk between the
immune system, inflammation, and Müller glial behavior shapes regeneration potential
in the mammalian retina, and may identify promising avenues for promoting
regeneration in human patients with retinal degenerative diseases.
Status | Active |
---|---|
Effective start/end date | 1/1/24 → 12/31/24 |
Funding
- Retina Research Foundation: $45,000.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.